These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9562860)

  • 21. HIV-1 gp41 by N-domain binds the potential receptor protein P45.
    Xiao Y; Wu W; Dierich MP; Chen Y
    Int Arch Allergy Immunol; 2000 Mar; 121(3):253-7. PubMed ID: 10729785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62.
    Chen YH; Xiao Y; Wu W; Yang J; Sui S; Dierich MP
    AIDS; 1999 Jun; 13(9):1021-4. PubMed ID: 10397530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.
    Mühle M; Lehmann M; Hoffmann K; Stern D; Kroniger T; Luttmann W; Denner J
    PLoS One; 2017; 12(3):e0173454. PubMed ID: 28282446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1.
    Ding J; Lu Y; Chen Y
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):123-7. PubMed ID: 11024351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDa.
    Chen YH; Böck G; Vornhagen R; Steindl F; Katinger H; Dierich MP
    Immunol Lett; 1993 Jul; 37(1):41-5. PubMed ID: 8225405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human and murine monoclonal antibodies directed against a conserved sequence from gp41 (aa583-599) of human immunodeficiency virus type 1.
    Ebersold A; Boyer V; Klasse PJ; Holnigue M; Fraisier C; Cocchi JM; Pipkorn R; Blomberg J; Desgranges C
    Res Virol; 1992; 143(3):179-91. PubMed ID: 1381515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41.
    Wang Z; Liu Z; Cheng X; Chen YH
    Microbiol Immunol; 2005; 49(8):703-9. PubMed ID: 16113499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV.
    Lim K; Ho JX; Keeling K; Gilliland GL; Ji X; Rüker F; Carter DC
    Protein Sci; 1994 Dec; 3(12):2233-44. PubMed ID: 7538846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.
    Conley AJ; Kessler JA; Boots LJ; Tung JS; Arnold BA; Keller PM; Shaw AR; Emini EA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3348-52. PubMed ID: 7512731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neutralizing epitope ELDKWA on HIV-1 gp41: genetic variability and antigenicity.
    Dong XN; Wu Y; Chen YH
    Immunol Lett; 2005 Oct; 101(1):81-6. PubMed ID: 15951025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5.
    Kusov YY; Zamjatina NA; Poleschuk VF; Michailov MI; Morace G; Eberle J; Gauss-Müller V
    Antiviral Res; 2007 Feb; 73(2):101-11. PubMed ID: 17014915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF
    J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
    McLain L; Brown JL; Cheung L; Reading SA; Parry C; Jones TD; Cleveland SM; Dimmock NJ
    Arch Virol; 2001; 146(1):157-66. PubMed ID: 11266210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production.
    Barcova M; Kacani L; Speth C; Dierich MP
    J Infect Dis; 1998 Apr; 177(4):905-13. PubMed ID: 9534962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.